Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Accumulated Expenses (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Accumulated Expenses for 17 consecutive years, with $376.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 4.24% year-over-year to $376.2 million, compared with a TTM value of $376.2 million through Dec 2025, up 4.24%, and an annual FY2025 reading of $369.3 million, up 6.25% over the prior year.
  • Accumulated Expenses was $376.2 million for Q4 2025 at Dolby Laboratories, up from $369.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $376.5 million in Q1 2025 and bottomed at $225.8 million in Q4 2021.
  • Average Accumulated Expenses over 5 years is $299.0 million, with a median of $299.0 million recorded in 2024.
  • The sharpest move saw Accumulated Expenses soared 52.62% in 2023, then fell 19.02% in 2024.
  • Year by year, Accumulated Expenses stood at $225.8 million in 2021, then increased by 1.99% to $230.3 million in 2022, then soared by 42.04% to $327.2 million in 2023, then rose by 10.31% to $360.9 million in 2024, then grew by 4.24% to $376.2 million in 2025.
  • Business Quant data shows Accumulated Expenses for DLB at $376.2 million in Q4 2025, $369.3 million in Q3 2025, and $317.4 million in Q2 2025.